Preimplantation genetic screening PGS can benefit any couple at risk from passing on
genetic\chromosomal abnormalities.

Promoting excellence and professionalism in the delivery of laboratory services through patient – focused,
cost – effective diagnostic services.

The GenaTi team of researchers and scientists continues to work tremendously hard in order to set up new research
priorities and strategic directions for the GenaTi that are crucial to strengthening Saudi Arabia's health care system.

GenaTi contributes to the prevention of genetic diseases in the Kingdom of Saudi Arabia by offering
pre-implantation genetic diagnosis and screening in its new IVF clinic


Cytogenetic services provide high quality analysis for the detection of both constitutional chromosomal aberrations as well as abnormalities related to hematological malignancies. Routine and high-resolution karyotyping, Fluorescent In situ Hybridization (FISH), and array Comparative Genomic Hybridization (aCGH) are available to diagnose suspected chromosomal abnormalities in blood, solid tissues or prenatal samples. Cytogenetic analysis of malignancies (karyotyping and use of several available FISH probes) will provide information regarding malignancies, their prognosis and treatment strategies.

Our cytogenetics laboratory is CAP (College of American Pathologist) accredited. Recognition by CAP authenticates that the laboratory meets the highest possible quality control standards at every stage of testing.

The Cytogenetics Laboratory provides the following comprehensive testing services:

Standard Karyotyping

Changes that affect the number and/or structure of the chromosomes can cause problems with growth, development and related body functions. However, some chromosomal changes may have no effect on a person’s health. Standard G-banding chromosomal analyses are performed on all tissue types for diagnosis of congenital anomalies, mental retardation, leukemia, lymphoma or other hematological disorders and solid neoplasms.

Chromosome Analysis available for:
  Peripheral blood
  Bone Marrow
  Solid Tumors
  Amniotic Fluid
  Chorionic villi
  Cord Blood (Prenatal)
  Skin biopsy
  Fragile X Syndrome
  Breakage studies:
  Fanconi's Anemia
  Ataxia Telangiectasia

Fluorescent In Situ Hybridization (FISH) analysis

A powerful tool for rapid detection of certain chromosomal abnormalities that is undetectable or difficult to be characterized by conventional cytogenetic methods. FISH is utilized as a valuable adjunct to traditional cytogenetics for screening several abnormalities such as marker chromosome, complex translocation, subtle translocations or deletions involving chromosomal ends, microdeletion syndrome, numerical aberrations of chromosomes and suspected aneuploidy (prenatal diagnosis).

FISH can usually be performed on the same specimen submitted for chromosome studies. Briefly, metaphase chromosomes or interphase nuclei are denatured on the slide, as is the fluorescently labeled DNA probe. The probe and the chromosomes/nuclei are then hybridized, slides are washed, counterstained and analyzed by fluorescent microscopy.

At GenaTi, FISH analyses is available for the following conditions:

Microdeletion syndrome Probes
  DiGeorge / Velocardiofacial syndrome (22q11.2)
  Prader-Willi / Angelman syndrome (15q11-q13)
  Williams syndrome (7q11.23)
  Miller-Dieker syndrome (17p13.3)
  Smith-Magenis syndrome (17p11.2)
  Cri-du-Chat syndrome (5p15.2)
  Wolf-Hirschhorn syndrome (4p16.3)
  Kallmann syndrome / (STS) (Xp22.3)
  1p36 deletion syndrome
  SRY (Yp11.3)

Prenatal screening probe
  Screening for numerical aberration of chromosomes (13, 21, 18, X & Y)

Oncology/ Hemato-oncolgy Probes
 BCR/ABL translocation probe t(9;22)(q34;q11.2)
 CBFB Break Apart 16p13.11/16q22.1
 AML1/ETO (RUNX1/RUNX1T1) 21q22.12/8q21.3
 PML/RAR? (RARA) 15q24.1/17q21.1-q21.2
 RP1 deletion (13q14)
 BCL6 (3q27.3)
 IgH (14q32.33)
 c-MYC (8q24.21)
 TP53 (17 p13.1)

Other Probes
  Centromeric probe
  Whole chromosome painting probes
  Telomeric probe
  Arm-specific painting probes

Comparative Genomic Hybridization array (aCGH) Analysis

CGH array is a high resolution analysis with superior detection and accuracy rate for copy number variations (CNV) and chromosomal alterations that are too small to be appreciated by standard chromosomal analysis.

CGH array is performed at the DNA level and compares its content in relation to a universal reference. Test DNA and reference samples are then hybridized to the array. The arrays are scanned and the intensities of the fluorescence are plotted as a ratio at each oligonucleotide probe. These ratios can then be interpreted as representing either a loss or a gain of DNA. A copy number change is considered only when three or more adjacent oligonucleotides are shown to be duplicated or deleted (with an average size of ~ 100 kb).

(aCGH) can help in diagnosis of the following conditions:
 Developmental delays
 Intellectual disability
 Dysmorphic features
 Congenital anomalies
 Family Screening
 Parental identity
 Array Confirmation

Please note:
aCGH cannot detect polyploidy, balanced chromosomal rearrangements, mosaicism, small duplications, deletions or point mutations below the resolution of the used array. Clinical consultations by experts may be necessary for any anomaly discovered.